1
submitted 10 months ago by [email protected] to c/[email protected]

FDA approval for Novartis' Cosentyx to treat moderate-severe hidradenitis suppurativa in adults, offering relief for chronic skin Treatment

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here
this post was submitted on 01 Nov 2023
1 points (100.0% liked)

Random stuff that gets sent to the Fediverse

1 readers
1 users here now

founded 1 year ago
MODERATORS